electroCore, Inc. (ECOR) Dividend History

Company News

• electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

  electroCore, Inc. has completed the acquisition of NeuroMetrix, Inc., gaining access to the Quell platform and positioning itself as a leader in non-invasive bioelectronic technologies for chronic pain and wellness markets.

  GlobeNewswire Inc.
• gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

  A study presented at the 2025 International Brain Injury Association World Congress found that the use of gammaCore non-invasive vagus nerve stimulation (nVNS) significantly improved concussive symptoms in patients with mild traumatic brain injury, regardless of the time since injury.

  GlobeNewswire Inc.
• electroCore to Participate at the Needham Virtual Healthcare Conference

  electroCore, Inc. (ECOR) announced that its CEO and CFO will participate in the Needham Virtual Healthcare Conference on April 10, 2025, hosting a group presentation and one-on-one meetings.

  GlobeNewswire Inc.
• electroCore to Participate at Upcoming Investor Conferences

  electroCore, Inc. announced that its Chief Financial Officer, Joshua Lev, will participate in two upcoming investor conferences, the 37th Annual Roth Conference and the LSI USA '25 conference, to engage with investors.

  GlobeNewswire Inc.
• Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

  A clinical trial conducted by the Air Force Research Laboratories (AFRL) found that non-invasive vagus nerve stimulation (nVNS) can accelerate sensorimotor learning in USAF simulator-based pilot training.

  GlobeNewswire Inc.